Annji Pharmaceutical Co., Ltd.(TW:7754)
NT$69.40+8.20 (+13.40%)
TW:7754
Annji Pharmaceutical Co., Ltd. Revenue
NT$69.40
At close:+8.20 (+13.40%)
Annji Pharmaceutical Co., Ltd. (7754) Revenue
Annji Pharmaceutical Co., Ltd. Revenue
Annji Pharmaceutical Co., Ltd. had a revenue of 540.00K in the quarter ending Jun 30, 2026, with 28.88%. This bring the company's revenue in the last twelve months to 959.00K, Decreased 87.30%. In the fiscal year ending Dec 31, 2025, Annji Pharmaceutical Co., Ltd. had annual revenue of 7.55M with -92.17% growth.
- Revenue (ttm)
- 959.00K
- Revenue Growth
- -95.98%
- P/S Ratio
- 929.35
- Revenue/Employee
- TWD 94,400
- Employees
- 80
- Market Cap
- TWD 7.02B
Revenue Chart
Annji Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.55M | -88.90M | -92.17% |
| Dec 31, 2024 | 96.45M | -47.08M | -32.80% |
| Dec 31, 2023 | 143.53M | 141.90M | 8727.18% |
| Dec 31, 2022 | 1.63M | 191.00K | 13.31% |
| Dec 31, 2021 | 1.44M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.